Read the Technology Review Article
TR35 Honorees to be Recognized at Technology Review’s emtech MIT 2011 Conference in October
CAMBRIDGE, MA – August 23, 2011 – Pathogenica, Inc. today announced that Yemi Adesokan has been recognized by Technology Review magazine as a TR35 Honoree for 2011. The TR35 recognizes the world’s top innovators under the age of 35, spanning energy, medicine, computing, communications, nanotechnology, and other emerging fields.
Yemi Adesokan has been honored for his work in the application of next generation sequencing to clinical diagnostics and was selected as a member of the TR35 class of 2011 by a panel of expert judges and the editorial staff of Technology Review, who evaluated more than 300 nominations. He will join other TR35 honorees in discussing their achievements at the emtech MIT 2011 conference, taking place at the MIT Media Lab in Cambridge October 18-19, 2011. All of the TR35 winners for 2011 will be featured in the September/October issue of Technology Review and online at http://www.technologyreview.com/tr35/.“Technology innovation is key to driving growth and progress in the areas of research, medicine, business and economics,” said Jason Pontin, editor-in-chief and publisher of Technology Review. “This year’s group of TR35 recipients is driving the next wave of transformative technology and making an impact on the way we live, work and interact. We look forward to profiling and working with these technology leaders each year, and watching their continued advancement in their respective fields.”
Adesokan founded Pathogenica with genomics pioneer and Harvard professor George Church in 2009 in order to commercialize applications of pathogen sequencing. Pathogenica’s test kits are able to identify the presence of many pathogen variants within a complex sample by reading their nucleic acid sequence, allowing for physicians to screen for multiple diseases with accurate results and a rapid turnaround.
“Sequencing technologies have improved million-fold in the past seven years, bringing scientists a wealth of individual genomics solutions. The key now is to employ the data to improve clinical practice," said Church. The goals of the Personal Genome Project, BioweatherMap [a research project founded with Adesokan], and various pathogen genome sequencing efforts globally, have been to improve human welfare. Pathogenica’s next generation sequencing tests are among the first tests that will leverage these to bring clear benefit to patients in the clinic, putting new tools for diagnosing and understanding diseases in the hands of front line physicians.”
Additional information about past and present TR35 winners and judges is available at www.technologyreview.com/tr35/. For more information about emtech MIT 2011 please visit: http://www.technologyreview.com/emtech.
About Pathogenica, Inc.
Pathogenica, based in Cambridge, MA, was founded in 2009 to pioneer commercial applications of pathogen sequencing. Pathogenica applies next generation DNA sequencing technology to meet the clinical demand for rapid multiplex identification of pathogens, drug resistance genes, and toxins in patient samples. The founding scientific advisory board is comprised of distinguished scientists in the field, including George Church, Harvard Medical School; Ronald Davis, Stanford University; W. Ian Lipkin, Columbia University; Andrew Onderdonk, Harvard Medical School; and Kun Zhang, University of California.
Pathogenica’s high throughput pathogen detection system is expected to deliver rapid and highly sensitive identification of a wide variety of pathogens from a patient sample, at a fraction of the cost of existing assays.
About Technology Review, Inc.
Technology Review is an independent media company owned by the Massachusetts Institute of Technology (MIT). More than two million people around the globe read our publications, in five languages and on a variety of digital and print platforms. We publish Technology Review magazine, the world’s oldest technology magazine (established 1899); daily news, analysis, opinion, and video; and Business Impact, which explains how new technologies are transforming companies, disrupting markets, or creating entirely new industries. We also produce live events such as the annual emtech MIT conference.
Contacts
For Pathogenica
Daniel Jackson
Business Manager
908-433-2628
djackson@pathogenica.com
For Technology Review
Cheryl Delgreco
Media Strategies
617-723-4004
cdelgreco@msipr.com